Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
JNMA J Nepal Med Assoc. 2022 Jan 15;60(245):1-5. doi: 10.31729/jnma.6768.
Coronavirus Disease 2019 pandemic is raging across the world and has affected pregnant women as well. There is limited information regarding COVID-19 in pregnant women. The study aimed to find the prevalence of COVID-19 among all pregnant women who delivered during the study period in a tertiary care center.
This was a descriptive cross-sectional study conducted in a tertiary care center from 16th August to 15th November 2020 after obtaining ethical clearance from the Institutional Review Committee of a tertiary care center. All the women who delivered in the hospital during the study period were enrolled and they were subjected to COVID-19 Reverse Transcriptase Polymerase Chain Reaction test. A total of 667 samples were taken using convenience sampling technique. Data were analyzed using the Statistical Package for the Social Sciences version 24 software. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data.
Among 667 pregnant women, the prevalence of COVID-19 was 47 (7.05%) (5.10-8.99 at 95% Confidence Interval). Though the majority of women were asymptomatic 40 (85.1%), 5 (10.64%) developed mild disease, 1 (2.12%) each had severe and critical COVID-19 pneumonia.
The prevalence of COVID-19 among pregnant women delivering in our center is similar to other studies done in similar settings. In our study, we found that the majority of women had been asymptomatic and were diagnosed on routine testing. Hence, it is important to test all pregnant women before delivery for Coronavirus Disease 2019 irrespective of the presence or absence of symptoms.
2019 年冠状病毒病大流行正在全球肆虐,也影响了孕妇。关于 COVID-19 在孕妇中的信息有限。本研究旨在调查在一家三级保健中心分娩的所有孕妇中 COVID-19 的患病率。
这是一项在获得一家三级保健中心的机构审查委员会的伦理批准后,于 2020 年 8 月 16 日至 11 月 15 日在三级保健中心进行的描述性横断面研究。在研究期间在医院分娩的所有妇女都被纳入,并对她们进行了 COVID-19 逆转录聚合酶链反应检测。使用方便抽样技术共采集了 667 份样本。使用社会科学统计软件包 24 版对数据进行分析。计算了 95%置信区间的点估计值以及二进制数据的频率和比例。
在 667 名孕妇中,COVID-19 的患病率为 47 例(7.05%)(95%置信区间为 5.10-8.99)。尽管大多数妇女无症状 40 例(85.1%),5 例(10.64%)发展为轻度疾病,1 例(2.12%)各有严重和危急的 COVID-19 肺炎。
我们中心分娩的孕妇 COVID-19 的患病率与在类似环境中进行的其他研究相似。在我们的研究中,我们发现大多数妇女无症状,是在常规检测中诊断出来的。因此,无论有无症状,在分娩前对所有孕妇进行 COVID-19 检测非常重要。